Skip to main content
BCTXZ logo

BCTXZ · BriaCell Therapeutics Corp. · Shareholders & Ownership

Track BCTXZ — free
$0.14 +0.01 (+10.66%) At close · Oct 27
Market Cap
$30.97M
Shares
8.70M
Volume · Oct 27 10.29K Avg daily vol (3M) 59.81K

Every disclosed holder of BCTXZ in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns BCTXZ

13F quarter Jun 30, 2026; this listing alone: insiders and shares outstanding are issuer-wide, so they are left out

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 631,698 —
Insiders (Forms 3, 4, 5) 0 —
13D/G-only blocks 0 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: shares outstanding is an issuer-wide count, not one listing's.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of BCTXZ

# Holder Shares
1
HEIGHTS CAPITAL MANAGEMENT, INC
13F CIK 1081698 · Unknown · Jun 30, 2026
313,379
2
SABBY MANAGEMENT, LLC
13F CIK 1535610 · Unknown · Jun 30, 2026
120,802
3
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F CIK 1446194 · Unknown · Jun 30, 2026
114,522
4
HRT FINANCIAL LP
13F CIK 1475597 · Unknown · Jun 30, 2026
67,935
5
TWO SIGMA SECURITIES, LLC
13F CIK 1450144 · Unknown · Jun 30, 2026
15,060

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1610820 CUSIP 107930307 Visit website Investor relations